Interactions of tryptamine derivatives with serotonin transporter species variants implicate transmembrane domain I in substrate recognition

Molecular Pharmacology

Volumn 59, Issue 3, 2001, Pages 514-523

  Adkins, Erika M ^a   Barker, Eric L ^b   Blakely, Randy D ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; MAZINDOL; SEROTONIN TRANSPORTER; TRYPTAMINE;

ARTICLE; DROSOPHILA MELANOGASTER; ENZYME SPECIFICITY; LIGAND BINDING; MUTAGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROTONIN UPTAKE; SPECIES DIFFERENCE; STRUCTURE ANALYSIS; SYNAPSE;

EID: 0035122827     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.59.3.514     Document Type: Article

References (47)

1. Probing domains contributing to the permeation pathway of the human serotonin transporter
2. Drugs and the treatment of psychiatric disorders: Depression and mania
3. Norepinephrine and serotonin transporters: Molecular targets of antidepressant drugs
4. Identification of a single amino acid, phenylalanine 586, that is responsible for high affinity interactions of tricyclic antidepressants with the human serotonin transporter
5. Structural determinants of neurotransmitter transport using cross-species chimeras: Studies on serotonin transporter
6. Chimeric human and rat serotonin transporters reveal domains involved in recognition of transporter ligands
7. Transmembrane domain I contributes to the permeation pathway for serotonin and ions in the serotonin transporter
8. High affinity recognition of serotonin transporter antagonists defined by species-scanning mutagenesis
9. Neurotoxicity of hydroxylated tryptamines: Structure-activity relationships
10. Tyrosine 140 of the γ-aminobutyric acid transporter GAT-1 plays a critical role in neurotransmitter recognition
11. Cloning and expression of a functional serotonin transporter from rat brain
12. Tails of serotonin and norepinephrine transporters: Deletions and chimeras retain function
13. Neurotransmitter transporters
14. Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenylpyridinium
15. Structure-activity relationships of serotonin transport: Relevance to nontricyclic antidepressant interactions
16. Determination of external loop topology in the serotonin transporter by site-directed chemical labeling
17. The third transmembrane domain of the serotonin transporter contains residues associated with substrate and cocaine binding
18. Transport-dependent accessibility of a cytoplasmic loop cysteine in the human dopamine transporter
19. Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (IC50) of an enzymatic reaction
20. Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters
21. Cloning of a serotonin transporter affected by antidepressants
22. Structure activity relations for the inhibition of 5-HT into rat hypothalamic homogenates by serotonin and tryptamine analogues
23. Structure-activity relationships of serotonin neurotoxins: Effects on serotonin uptake
24. Dopamine transporter transmembrane domain polar mutants: ΔG and ΔΔG values implicate regions important for transporter functions
25. 3H]Mazindol binding associated with neuronal dopamine and norepinephrine uptake sites
26. Species variations in transmembrane region V of the 5-hydroxytryptamine type 2A receptor alter the structure-activity relationship of certain ergolines and tryptamines
27. Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding
28. + transport
29. The region of dopamine transporter encompassing the 3rd transmembrane domain is crucial for function
30. Importance of valine at position 152 for the substrate transport and 2β-carbomethoxy-3β-(4-fluorophenyl)tropane binding of dopamine transporter
31. Dopamine transporter: Transmembrane phenylalanine mutations can selectively influence dopamine uptake and cocaine analog recognition
32. The spectrum of behaviors influenced by serotonin
33. Tyrosine-533 of rat dopamine transporter: Involvement in interactions with 1-methyl-4-phenylpyridinium and cocaine
34. Restriction-site independent formation of neurotransmitter transporter chimera
35. - neurotransmitter transporters
36. Transmembrane domain III plays an important role in ion biding and permeation in the glycine transporter GLYT2
37. The structure and function of norepinephrine, dopamine, and serotonin transporters
38. Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression
39. Antidepressant- and cocaine-sensitive human serotonin transporter: Molecular cloning, expression, and chromosomal localization
40. The molecular mechanism of "ecstasy" [3,4-methylenedioxymethamphetamine (MDMA)]: Serotonin transporters are targets for MDMA-induced serotonin release
41. 5-hydroxytryptamine (serotonin) receptor agonists and antagonists
42. Heterogeneity of antidepressant binding sites on the recombinant rat serotonin transporter SERT1
43. Pharmacological profile of antidepressants and related compounds at human monoamine transporters
44. Differential binding of tropane-based photoaffinity ligands on the dopamine transporter
45. Resolution of monoamine uptake into binding and translocation components